Multivalvular vs single-valve infective endocarditis: a systematic review and meta-analysis

Ioannis Kyriakoulis1, Andreas Tzoumas2, Konstantinos G Kyriakoulis3

  • 1Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Future Cardiology
|January 30, 2025
PubMed
Abstract

Insights

Multivalvular infective endocarditis (MIE) is linked to worse outcomes than single-valve infective endocarditis (SIE). MIE increases risks for mortality, heart failure, and embolic events, necessitating prompt diagnosis and treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Infective endocarditis (IE) involves heart valve colonization by microorganisms.
  • Single-valve infective endocarditis (SIE) is common, while multivalvular infective endocarditis (MIE) affects multiple valves.
  • Prognosis and complication risks for MIE versus SIE are not well-established.

Purpose of the Study:

  • To compare the clinical outcomes of MIE and SIE.
  • To evaluate the association between MIE and adverse events compared to SIE.

Main Methods:

  • Systematic literature search of MEDLINE and Scopus databases.
  • Inclusion of studies reporting on patients with MIE and SIE.
  • Analysis of outcomes including mortality, heart failure, embolic events, and need for surgery.

Main Results:

  • MIE was identified in 20.4% of patients across eleven studies.
  • MIE significantly increased risks for short-term mortality (RR: 1.29), one-year mortality (RR: 1.20), and heart failure (RR: 1.31).
  • MIE was also associated with higher rates of systemic embolic events (RR: 1.12) and need for surgery (RR: 1.22).

Conclusions:

  • Multivalvular infective endocarditis portends a poorer prognosis than single-valve infective endocarditis.
  • Increased clinical suspicion and timely intervention are crucial for managing MIE.
  • Findings highlight the importance of recognizing MIE for improved patient outcomes.